MANNHEIMIA HAEMOLYTICA VACCINE

摘要

THERE IS PROVIDED BY THIS INVENTION A NOVEL VACCINE FOR IMMUNIZING SMALL RUMINANTS AGAINST MANNHEINMIA HAEMOLYTICA INFECTION; PARTICULARLY MANNHEIMIA HAEMOLYTICA SEROTYPE A2 INFECTION. THE VACCINE IS COMPOSED OF INACTIVATED CULTURE OF MANNHEIMIA HAEMOLYTICA SEROTYPE A2 IN A DOSAGE EFFECTIVE TO IMMUNIZE SMALL RUMINANTS AGINST THE BACTERIA, IN COMBINATION WITH AN EXCIPIENT. THE VACCINE IS FORMULATED FOR INTRANASAL ADMINISTRATION INTO SMALL RUMINANTS. THERE IS FURTHER PROVIDED BY THIS INVENTION A NOVEL METHOD FOR PREPARING A VACCINE FOR IMMUNIZING SMALL RUMINANTS AGAINST MANNHEIMIA HAEMONTICA A2 INFECTION COMPOSED OF INACTIVATED CULTURE OF MANNHEIMIA HAEMOLYTICA SEROTYPE A2. FURTHER PROVIDED BY THIS INVENTION IS A NOVEL KIT FOR IMMUNIZING SMALL RUMINANTS AGAINST MANNHEIMIA HAEMOLYTICA A2 INFECTION COMPRISING AN INACTIVATED CULTURE OF MANNHEIMIA HAEMOLYTICA SEROTYPE A2 PREPARATION AND AN INTRANASAL DELIVERY DEVICE.